BeStock  
Stocks › Biotechnology › VERA

Vera Therapeutics VERA

US equityMarket cap rank #2729Biotechnology
$25.45 −$1.30 (-4.86%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $24.88 -2.24%
Open$26.37
Prev close$26.75
Day range$25.16 – $27.15
Volume1.37M
Market cap$1.84B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership117.1%-2.67 pts vs. prior quarter
Institutions holding278+3 vs. prior quarter
Insider trades (recent)31 buys / 16 sellsNet buying
Short interest16.85% of floatDays to cover 8.5 · as of 30 Oct 2026
Short-sale volume share25.1%5-day average of daily volume

Short-sale volume as % of daily volume

12%21%30%39%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$9.63M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

−$10.9MSuper+$1.2MBig−$6.3MMid−$6.3MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 34.4% of shares outstanding.

Largest holders

  • BlackRock7.92%
  • Avoro Capital Advisors LLC7.92%
  • Longitude Capital Management Co., LLC7.46%
  • T. Rowe Price Group, Inc.5.55%
  • Deep Track Capital, LP5.53%
  • Deerfield Management Company, L.P.5.42%
  • State Street Global Advisors4.57%
  • Kynam Capital Management, LP4.00%

By investor type

  • Mutual Fund57.82%
  • Hedge Fund34.66%
  • VC/PE Fund18.53%
  • Public Company4.73%
  • Individual/Insider0.88%
  • Private Company0.87%
  • Government Pension Fund0.25%
  • Insurance Company0.20%

Reported short interest has fallen from 23.33% to 16.85% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Deutsche Asset & Wealth Management Mutual Fund 2026/Q3 +1,029,770 2.9%
Pictet Asset Management Limited Mutual Fund 2026/Q3 +589,831 2.5%
Putnam LLC Mutual Fund 2026/Q3 +291,747 0.4%
UBS Asset Management Mutual Fund 2026/Q3 +268,948 1.0%
Rhenman & Partners Asset Management AB Hedge Fund 2026/Q3 +242,500 0.3%
Davern Capital Partners, LP Hedge Fund 2026/Q3 +129,442 0.9%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +122,610 0.9%
Candriam, Société En Commandite Par Actions Mutual Fund 2026/Q3 +100,461 0.8%
American Century Investment Management Mutual Fund 2026/Q3 +85,852 1.3%
Morgan Stanley Public Company 2026/Q3 +2,425,794 3.8%
Logos Global Management, L.P. Hedge Fund 2026/Q3 +2,200,000 3.0%
State Street Global Advisors Mutual Fund 2026/Q3 +785,148 5.8%
Frontier Capital Management Mutual Fund 2026/Q3 +743,912 1.8%
BlackRock Mutual Fund 2026/Q3 +659,658 8.0%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +615,039 1.8%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
14 Sep 2026 Marshall Fordyce Chief Executive Officer Derivative Exercise and Sale -18,500 $37.00 288,537
10 Sep 2026 Joseph Young Senior VP of Finance & Chief Accounting Officer Derivative Exercise and Retained +5,000 $3.94 51,761
1 Sep 2026 Marshall Fordyce Chief Executive Officer Derivative Exercise and Sale -18,500 $35.12 288,537
2 Aug 2026 Nancy Boman Other Acquisition +44,987 – 44,987
2 Aug 2026 Nancy Boman Other Derivative Acquisition +63,011 $32.23 63,011
6 Jul 2026 Marshall Fordyce Chief Executive Officer Derivative Exercise and Sale -46,250 $43.59 288,537
22 Jun 2026 Marshall Fordyce Chief Executive Officer Derivative Exercise and Sale -18,500 $38.43 288,537
20 May 2026 Michael Morrissey Independent Chairperson Other Derivative Acquisition +17,084 $34.35 17,084
20 May 2026 Patrick Gerald Enright Independent Director Other Derivative Acquisition +17,084 $34.35 17,084
20 May 2026 Beth Seidenberg Independent Director Other Derivative Acquisition +17,084 $34.35 17,084
20 May 2026 Scott William Morrison Independent Director Other Derivative Acquisition +17,084 $34.35 17,084
20 May 2026 James Meyers Independent Director Other Derivative Acquisition +17,084 $34.35 17,084
20 May 2026 Andrew Cheng Independent Director Other Derivative Acquisition +17,084 $34.35 17,084
20 May 2026 Christy Oliger Independent Director Other Derivative Acquisition +17,084 $34.35 17,084
20 May 2026 Kimball Hall Other Derivative Acquisition +17,084 $34.35 17,084
11 May 2026 Marshall Fordyce Chief Executive Officer Derivative Exercise and Sale -18,500 $37.09 288,537
13 Apr 2026 Marshall Fordyce Chief Executive Officer Automatic Disposition -22,951 $45.51 288,537
22 Mar 2026 Jane Wright-Mitchell Chief Legal Officer Other Acquisition +42,403 – 42,403
22 Mar 2026 Jane Wright-Mitchell Chief Legal Officer Other Derivative Acquisition +56,850 $40.73 56,850
12 Mar 2026 Joseph Young Senior VP of Finance & Chief Accounting Officer Derivative Exercise and Retained +10,000 $3.94 46,761

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 12,141,556 16.8% 8.5
15 Oct 2026 13,587,185 18.9% 7.2
30 Sep 2026 17,240,397 23.9% 7.8
15 Sep 2026 17,035,040 23.6% 6.2
31 Aug 2026 19,873,297 27.6% 10.8
14 Aug 2026 16,814,429 23.3% 7.0

Discussion

No comments yet — be the first to weigh in on VERA.

Sign in to join the discussion.

Scroll to Top